Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture

Richard Filek1 Department of Pathology and Laboratory Medicine, Western University, London, ON, CanadaCorrespondence[email protected]

Phil Hooper2 Department of Ophthalmology, Western University, London, ON, Canada;3 Ivey Eye Institute, St. Joseph’s Health Care London, London, ON, Canada

Tom G Sheidow2 Department of Ophthalmology, Western University, London, ON, Canada;3 Ivey Eye Institute, St. Joseph’s Health Care London, London, ON, Canada

Hong Liu3 Ivey Eye Institute, St. Joseph’s Health Care London, London, ON, Canada

Subrata Chakrabarti1 Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada

Cindy ML Hutnik1 Department of Pathology and Laboratory Medicine, Western University, London, ON, Canada;2 Department of Ophthalmology, Western University, London, ON, Canada;3 Ivey Eye Institute, St. Joseph’s Health Care London, London, ON, Canada

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture

Citations (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date